Related references
Note: Only part of the references are listed.Performance of Idylla™RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer
Yusuke Makutani et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)
Colorectal Cancer Surveillance With Circulating Tumor DNA Assay
Alan P. Venook
JAMA NETWORK OPEN (2022)
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
Blanca Trujillo et al.
BRITISH JOURNAL OF CANCER (2022)
Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy
Aleksei Shefer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Liquid biopsy: current technology and clinical applications
Mina Nikanjam et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Circulating tumor cell isolation for cancer diagnosis and prognosis
Zicheng Deng et al.
EBIOMEDICINE (2022)
Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
Shicai Liu et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)
Liquid biopsy enters the clinic - implementation issues and future challenges
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late
Maarten J. IJzerman et al.
DIAGNOSTICS (2021)
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms
Hanna Tukachinsky et al.
CLINICAL CANCER RESEARCH (2021)
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors
Pamela Pinzani et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring
Ivana Martins et al.
GENES (2021)
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine
Maria Panagopoulou et al.
CANCERS (2021)
Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment
Brice Pastor et al.
MOLECULAR ONCOLOGY (2021)
Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis
Zhengfan Gao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Exosomes: A Forthcoming Era of Breast Cancer Therapeutics
Banashree Bondhopadhyay et al.
CANCERS (2021)
Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer
Haiying Yu et al.
CANCER BIOMARKERS (2020)
Liquid Biopsy Applications in the Clinic
Dake Chen et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Liquid Biopsy for Cancer: Review and Implications for the Radiologist
Jacob J. Underwood et al.
RADIOLOGY (2020)
Comparison of Tissue-Based Molecular Markers in Younger versus Older Patients with Colorectal Neoplasia
Paul J. Limburg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Perspectives of the Application of Liquid Biopsy in Colorectal Cancer
Yuhan Ding et al.
BIOMED RESEARCH INTERNATIONAL (2020)
KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
Mariantonia Nacchio et al.
JOURNAL OF THORACIC DISEASE (2020)
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients
Chiara Foroni et al.
BIOMEDICINES (2020)
Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients
Xiaojing Xu et al.
BMC CANCER (2020)
SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
Baoliang Li et al.
DISEASE MARKERS (2020)
Liquid Biopsy: Application in Early Diagnosis and Monitoring of Cancer
Junjie Feng et al.
SMALL STRUCTURES (2020)
Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer
Xue Wang et al.
THORACIC CANCER (2020)
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
De-Shen Wang et al.
GUT (2019)
Urinary biomarkers in bladder cancer: where do we stand?
Abhishek Bhat et al.
CURRENT OPINION IN UROLOGY (2019)
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)
Hiroaki Akamatsu et al.
LUNG CANCER (2019)
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
Gabriele De Rubis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma
Matthew Egyud et al.
ANNALS OF THORACIC SURGERY (2019)
Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition
Michael Oellerich et al.
CLINICA CHIMICA ACTA (2019)
Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value
Yao Cui et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
Roshni Ann Mathai et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing
Simon Herrmann et al.
MOLECULAR ONCOLOGY (2019)
A five-miRNA panel in plasma was identified for breast cancer diagnosis
Minghui Li et al.
CANCER MEDICINE (2019)
Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations
Jason C. Poole et al.
PLOS ONE (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer
Ying Ying Su et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Exploiting Exosomes in Cancer Liquid Biopsies and Drug Delivery
Coy Austin Fitts et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
Qian Chen et al.
ONCOTARGETS AND THERAPY (2019)
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
Rui Batista et al.
FRONTIERS IN GENETICS (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma
Lu-Nan Qi et al.
CANCER RESEARCH (2018)
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Karinna Almodovar et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip
Wanlei Gao et al.
TALANTA (2018)
Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer
Sina Halvaei et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy
Yue-Feng Wen et al.
PLOS ONE (2018)
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
Khurum H. Khan et al.
CANCER DISCOVERY (2018)
Analysis of solid tumor mutation profiles in liquid biopsy
Sai A. Balaji et al.
CANCER MEDICINE (2018)
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
Jesus Garcia-Foncillas et al.
BRITISH JOURNAL OF CANCER (2018)
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial
J. Alfred Witjes et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance
Renate Pichler et al.
BJU INTERNATIONAL (2018)
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Raffaele Palmirotta et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
S. Chen et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
Yi-Chen Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
Yvette N. Lamb et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population
Yi-Xin Hao et al.
ONCOLOGY LETTERS (2017)
Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
Kristina E. Aaltonen et al.
ONCOTARGET (2017)
The biology and function of exosomes in cancer
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2016)
Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Laura F. Ogle et al.
JOURNAL OF HEPATOLOGY (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®
Tobias M. Gorges et al.
PLOS ONE (2016)
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Ellen Heitzer et al.
CLINICAL CHEMISTRY (2015)
Circulating tumor cells as promising novel biomarkers in solid cancers
Evi S. Lianidou et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2014)
Digital-Direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma
Claudia Pfitzner et al.
SCIENTIFIC REPORTS (2014)
Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients
Valerie Taly et al.
CLINICAL CHEMISTRY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Jorja D. Warren et al.
BMC MEDICINE (2011)
Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer
Suhail K. Mithani et al.
CLINICAL CANCER RESEARCH (2007)
Share Paper
